While literature strongly supports a requisite role for PRMT5 in the context of large cell lymphomas, emerging evidence now suggests aberrant PRMT5 expression additionally disrupts critical regulatory mechanisms and contributes to tumor progression in CLL28. Here, PRMT5 is linked to anaplastic large cell lymphoma.